I aim to provide high quality care that is safe, compassionate and with the patients best interests and expectations in mind. We make sure that each and every patient has a full understanding of their options, and through shared decision making, develop an individualized plan to meet goals.
Eric Fynn-Thompson, MD
Plastic & Reconstructive Surgery
Practices In:
Quincy
Patients Seen:
All Ages
Board Certifications
American Board of Plastic Surgery, Subspecialty Certification of Added Qualification in Hand Surgery
Languages
English
Awards & Accolades
Student National Medical Association Regional Research Forum – First place winner for poster presentation
1999
Hinton-Wright Society Pfeiffer Fellow
1998
Merck-Massachusetts General Hospital, Minority Summer Research Fellowship Award
1997
Clinical Interests
Breast and body contouring, Hand surgery
Personal Interests
Golf, Travel and spending time with family
Memberships
American Society for Surgery of the Hand
American Society of Plastic Surgeons
https://youtu.be/XS36OVxMlKM?enablejsapi=1
Quincy Medical Group Surgery Center
Blessing Hospital
Blessing Surgery Center
School
Massachusetts Institute of Technology
Graduation Date:
1998
Degree:
BS, Biology
Harvard Medical School
Graduation Date:
2002
Degree:
MD
Residency
Brown University
General Surgery
Brown University
Plastic Surgery, Chief Resident
Fellowships
University of Cincinnati Hospital, Mary S. Stern Orthopedic Hand Surgery Fellowship
Hand Surgery Specialists
Provider’s Publications
Foley J, Fynn-Thompson E, Stern P. The Scaphoid: New Tricks for an Old Bone. Chapter: Proximal Row Carpectomy for Scaphoid Non-Union. Thieme, 2011; Chapter 37:325-329
2011
Calfee R, Fynn-Thompson E, Stern P. Surgeon Bias in the medical record. Orthopedics 2009; October Volume 32, Issue 10.
October 2009
Fynn-Thompson E, Cheng H, Teixeira J. Inhibition of steroidogenesis in Leydig cells by Müllerian Inhibiting Substance. Endocrinology 2003; 211:99-104
2003
Teixeira J, Fynn-Thompson E, Payne AH, Donahoe PK. Müllerian Inhibiting Substance regulates Androgen Synthesis at the transcriptional level. Endocrinology 1999; 140:4732-8
1999
Fynn-Thompson E. Müllerian Inhibiting Substance induces apoptosis in a rat Leydig tumor cell line. MIT Biology Undergraduate Journal 1998; 41-47
1998
Patent 6,673,352 (Issued 2004): Donahoe PK, Teixeira J, Fynn-Thompson E. Clinical use of Müllerian Inhibiting Substance in the treatment of conditions of Androgen excess.
Procedures
Arm Lift (Brachioplasty), Botox, Breast Augmentation - Implants, Breast Implants, Breast Lift (Mastopexy), Breast Reconstruction – Implant-Based, Breast Reduction (Reduction Mammaplasty), Carpal Tunnel Release, Dupuytrens Surgery, Elbow Nerve Release, Excess Skin Removal, Eyelid Lift (Blepharoplasty) – Upper, Ganglion Cyst Procedures, Hand Surgery, Mass, Lesions, & Cyst Removal, Smartlipo Laser Body Contouring/Laser-Assisted Lipolysis, Tendon Repair, Thumb Arthritis Surgery, Trigger Finger Surgery, Tummy Tuck (Abdominoplasty), Tummy Tuck with Liposuction (Lipo-Abdominoplasty), Wrist Arthritis Surgery
Conditions
Breast Cancer Reconstruction, Carpal Tunnel, Excess & Sagging Skin, Forehead Wrinkles, Frown Lines, Ganglion Cysts, Hand Trauma/Hand Fractures, Hooded Upper Eyelids, Macromastia (Large Breasts), Mass, Lesions, and Cysts, Tendon Tears, Thumb Arthritis, Trigger Finger, Wrist Arthritis
Comments